(Q28273315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1045-1063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobials: new solutions badly needed

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Detection of novel secondary metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Novel antibacterials: a genomics approach to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

How the pharmaceutical industry brings an antibiotic drug to market in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

In vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Discovery of a novel and potent class of FabI-directed antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Multiple antibiotic resistance and efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Salmonella typhimurium and Escherichia coli mutants with increased outer membrane permeability to hydrophobic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Cytotoxicity tests for high-throughput drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Applications of microarrays in the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Practical aspects of mutagenicity testing strategy: an industrial perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

The Ames Salmonella/microsome mutagenicity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Mechanism of quinolone mutagenicity in bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

SOS response promotes horizontal dissemination of antibiotic resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Genotoxicity testing: current practices and strategies used by the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

High throughput Comet assay using 96-well plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Antimicrobial properties and mode of action of the pyrrothine holomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Membrane damage to bacteria caused by single and combined biocides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Anti-staphylococcal activity and mode of action of clofazimine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Pharmacodynamic effects of subinhibitory antibiotic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Development of a Screening Assay to Measure the Loss of Antibacterial Activity in the Presence of Proteins: Its Use in Optimizing Compound Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

The antimicrobial activity of fusidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

The role of mutators in the emergence of antibiotic-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

The biological cost of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Proteomic approach to understanding antibiotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

PCR-based ordered genomic libraries: a new approach to drug target identification for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

DNA microarray analysis of the expression profile of Escherichia coli in response to treatment with 4,5-dihydroxy-2-cyclopenten-1-one

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

A general genetic approach in Escherichia coli for determining the mechanism(s) of action of tumoricidal agents: application to DMP 840, a tumoricidal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Peptide deformylase as an antibacterial drug target: target validation and resistance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

An array of target-specific screening strains for antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Regulated ectopic expression and allelic-replacement mutagenesis as a method for gene essentiality testing in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

A genome-wide strategy for the identification of essential genes in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Drug target validation: lethal infection blocked by inducible peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Mechanism of fluoroquinolone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Stress-based identification and classification of antibacterial agents: second-generation Escherichia coli reporter strains and optimization of detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.8.1045

10.1517/13543784.13.8.1045

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268641%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017